Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients

Genomic tests are the fastest growing sector in medicine and medical science, yet there remains a dearth of research on access to pharmacogenomic tests and medications. The objective of this study is to explore providers’ and patients’ experiences and views on test access as well as strategies used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ann Chen, Mazor, Kathleen M., Ceccarelli, Rachel, Loomer, Stephanie, Lu, Christine Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748629/
https://www.ncbi.nlm.nih.gov/pubmed/29140263
http://dx.doi.org/10.3390/jpm7040017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748629/
https://www.ncbi.nlm.nih.gov/pubmed/29140263
http://dx.doi.org/10.3390/jpm7040017

Ejemplares similares